We review the main results obtained by the BRAHMS collaboration on the properties of hot and dense hadronic and partonic matter produced in ultrarelativistic heavy ion collisions at RHIC. A particular focus of this paper is to discuss to what extent the results collected so far by BRAHMS, and by the other three experiments at RHIC, can be taken as evidence for the formation of a state of deconfined partonic matter, the so called quark-gluon-plasma (QGP). We also discuss evidence for a possible precursor state to the QGP, i.e. the proposed Color Glass Condensate.
We report on a study of the transverse momentum dependence of nuclear modification factors R dAu for charged hadrons produced in deuteron + gold collisions at √ sNN = 200 GeV, as a function of collision centrality and of the pseudorapidity (η = 0, 1, 2.2, 3.2) of the produced hadrons. We find a significant and systematic decrease of R dAu with increasing rapidity. The mid-rapidity enhancement and the forward rapidity suppression are more pronounced in central collisions relative to peripheral collisions. These results are relevant to the study of the possible onset of gluon saturation at energies reached at BNL RHIC.
Charged particle pseudorapidity densities are presented for the 197 Au + 197 Au reaction at √ s NN = 130 GeV. These densities provide an essential characterization of the underlying reactions mechanisms for ultra-relativistic heavy-ion collisions. This talk details how the global charged particle yields are measured at BRAHMS and presents some preliminary results from the analysis of data taken during the first year of the RHIC experimental program.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.